Suppr超能文献

用于靶向基因转移至前列腺癌细胞的重组多功能生物大分子的研发

Development of a Recombinant Multifunctional Biomacromolecule for Targeted Gene Transfer to Prostate Cancer Cells.

作者信息

Hatefi Arash, Karjoo Zahra, Nomani Alireza

机构信息

Department of Pharmaceutics, Rutgers The State University of New Jersey , Piscataway, New Jersey 08854, United States.

Rutgers Cancer Institute of New Jersey , New Brunswick, New Jersey 08903, United States.

出版信息

Biomacromolecules. 2017 Sep 11;18(9):2799-2807. doi: 10.1021/acs.biomac.7b00739. Epub 2017 Aug 24.

Abstract

The objective of this study was to genetically engineer a fully functional single chain fusion peptide composed of motifs from diverse biological and synthetic origins that can perform multiple tasks including DNA condensation, cell targeting, cell transfection, particle shielding from immune system and effective gene transfer to prostate tumors. To achieve the objective, a single chain biomacromolecule (vector) consisted of four repeatative units of histone H2A peptide, fusogenic peptide GALA, short elastin-like peptide, and PC-3 cell targeting peptide was designed. To examine the functionality of each motif in the vector sequence, it was characterized in terms of size and zeta potential by Zetasizer, PC-3 cell targeting and transfection by flowcytometry, IgG induction by immunogenicity assay, and PC-3 tumor transfection by quantitative live animal imaging. Overall, the results of this study showed the possibility of using genetic engineering techniques to program various functionalities into one single chain vector and create a multifunctional nonimmunogenic biomacromolecule for targeted gene transfer to prostate cancer cells. This proof-of-concept study is a significant step forward toward creating a library of vectors for targeted gene transfer to any cancer cell type at both in vitro and in vivo levels.

摘要

本研究的目的是通过基因工程构建一种功能齐全的单链融合肽,该肽由来自不同生物和合成来源的基序组成,能够执行多种任务,包括DNA凝聚、细胞靶向、细胞转染、使颗粒免受免疫系统攻击以及有效地将基因转移至前列腺肿瘤。为实现这一目标,设计了一种由组蛋白H2A肽的四个重复单元、融合肽GALA、短弹性蛋白样肽和PC-3细胞靶向肽组成的单链生物大分子(载体)。为了检测载体序列中每个基序的功能,通过Zetasizer对其大小和zeta电位进行了表征,通过流式细胞术检测了PC-3细胞靶向和转染情况,通过免疫原性测定检测了IgG诱导情况,并通过定量活体动物成像检测了PC-3肿瘤转染情况。总体而言,本研究结果表明利用基因工程技术将各种功能编程到一个单链载体中并创建一种用于向前列腺癌细胞进行靶向基因转移的多功能非免疫原性生物大分子是有可能的。这项概念验证研究朝着创建一个用于在体外和体内水平向任何癌细胞类型进行靶向基因转移的载体库迈出了重要的一步。

相似文献

本文引用的文献

1
Progress and problems with the use of suicide genes for targeted cancer therapy.用于靶向癌症治疗的自杀基因的进展与问题
Adv Drug Deliv Rev. 2016 Apr 1;99(Pt A):113-128. doi: 10.1016/j.addr.2015.05.009. Epub 2015 May 22.
8
Immunogenicity of therapeutics: a matter of efficacy and safety.治疗药物的免疫原性:关乎疗效与安全。
Expert Opin Drug Discov. 2010 Nov;5(11):1067-79. doi: 10.1517/17460441.2010.514326. Epub 2010 Sep 1.
10
Retro-orbital injections in mice.眶后注射(Retro-orbital injections)在小鼠中。
Lab Anim (NY). 2011 May;40(5):155-60. doi: 10.1038/laban0511-155.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验